Ms. Kimberly Jo Sedbrook, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2 Carlson Pkwy N Ste 100, Plymouth, MN 55447 Phone: 952-473-1286 Fax: 952-473-7281 |
Adam Schmitt, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2 Carlson Pkwy N Ste 240, Plymouth, MN 55447 Phone: 763-367-7108 |
Dr. H Spencer Holmes, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1295 Walnut Grove Ln N, Plymouth, MN 55447 Phone: 952-237-4147 Fax: 952-993-0333 |
Amit Mittal, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 15655 37th Ave N Ste 100, Plymouth, MN 55446 Phone: 630-632-2648 Fax: 612-230-8769 |
Rachel Lynn Stevens, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2 Carlson Pkwy N Ste 100, Plymouth, MN 55447 Phone: 952-473-1286 |
Dr. Valda Noreen Kaye, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9900 13th Avenue North, Suite 2a, Plymouth, MN 55441 Phone: 763-525-0363 Fax: 763-525-0369 |
News Archive
Physicians for a National Health Program (PNHP) today welcomed the American College of Physicians' (ACP) endorsement of single-payer Medicare for All.
CombiMatrix Corporation today announced that it received a written notice from The Nasdaq Stock Market (the "Notice") on November 17, 2010 indicating that the Company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Global Market (as set forth in Nasdaq Listing Rule 5450(b)(1)(A)) because the Company's stockholders' equity is below The Nasdaq Global Market minimum stockholders' equity listing requirement of $10,000,000.
Celldex Therapeutics, Inc. today announced that the Company's first antibody-drug conjugate (ADC) product candidate, CDX-011 (formerly CR011-vcMMAE), for the treatment of locally advanced or metastatic breast cancer will be the subject of a poster presentation at the 2009 San Antonio Breast Cancer Symposium.
Researchers from Case Western Reserve University School of Medicine have discovered how unusually long strands of RNA help colon cancer cells avoid death, allowing unregulated growth.
The liver scarring of α1-antitrypsin deficiency, the most common genetic cause for which children undergo liver transplantation, might be reversed or prevented with a medication that has long been used to treat seizures, according to findings from Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh School of Medicine that will published in Science and are available online today through the Science Express website.
› Verified 4 days ago